DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- DermWire TV
FDA Approves Rosacea Treatment Emrosi
- DermWire TV
DermWire TV Extra: Dr. Bunick on BPO Study
Christopher Bunick, MD, PhD, FAAD
Melinda Gooderham, MSc, MD, FRCPC